<?xml version="1.0" encoding="UTF-8"?>
<p>Chikungunya virus (CHIKV) is a re-emerging alphavirus transmitted to humans by 
 <italic>Aedes</italic> mosquitoes that has caused massive epidemics in Africa [
 <xref rid="pntd.0007327.ref001" ref-type="bibr">1</xref>–
 <xref rid="pntd.0007327.ref003" ref-type="bibr">3</xref>]; in the Indian Ocean islands [
 <xref rid="pntd.0007327.ref004" ref-type="bibr">4</xref>–
 <xref rid="pntd.0007327.ref006" ref-type="bibr">6</xref>]; in Southeast Asia [
 <xref rid="pntd.0007327.ref007" ref-type="bibr">7</xref>,
 <xref rid="pntd.0007327.ref008" ref-type="bibr">8</xref>]; in the Americas [
 <xref rid="pntd.0007327.ref009" ref-type="bibr">9</xref>,
 <xref rid="pntd.0007327.ref010" ref-type="bibr">10</xref>]; and in Italy, where the first European outbreak occurred in 2007 [
 <xref rid="pntd.0007327.ref011" ref-type="bibr">11</xref>,
 <xref rid="pntd.0007327.ref012" ref-type="bibr">12</xref>]. CHIKV is known to target human epithelial and endothelial cells, fibroblasts and macrophages [
 <xref rid="pntd.0007327.ref013" ref-type="bibr">13</xref>–
 <xref rid="pntd.0007327.ref015" ref-type="bibr">15</xref>], as well as human muscle satellite cells [
 <xref rid="pntd.0007327.ref016" ref-type="bibr">16</xref>]. The virus is also suspected of neurotropism [
 <xref rid="pntd.0007327.ref017" ref-type="bibr">17</xref>,
 <xref rid="pntd.0007327.ref018" ref-type="bibr">18</xref>], which can lead to neurological complications [
 <xref rid="pntd.0007327.ref019" ref-type="bibr">19</xref>–
 <xref rid="pntd.0007327.ref022" ref-type="bibr">22</xref>].
</p>
